FDA Approves Zurzuvae
FDA Approves Zurzuvae (zuranolone) First Oral Treatment for Postpartum Depression August 04, 2023 — Today, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the […]
Read moreHome »
FDA Approves Zurzuvae (zuranolone) First Oral Treatment for Postpartum Depression August 04, 2023 — Today, the U.S. Food and Drug Administration approved Zurzuvae (zuranolone), the […]
Read more
FDA Approves Beyfortus (nirsevimab) for the Prevention of RSV Lower Respiratory Tract Disease in Infants July 17, 2023 — AstraZeneca and Sanofi’s Beyfortus (nirsevimab) has […]
Read more
FOSTER CITY, Calif.–(BUSINESS WIRE) July 14, 2023 — Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a […]
Read more